Scientists have detected resistance to artemisinin, a key malaria drug, for the first time among children in Africa with ...

Acquisition to support the global execution of BioNTech’s oncology strategy and provide full global rights to BNT327/PM8002, an investigational ...

Biotheus’ antibody drug targets PD-L1 and VEGF, a design that’s high on drugmakers’ radars after the success of Summit ...

BioNTech has agreed to acquire biotechnology company Biotheus for $800 million up front and up to $150 million in milestone payments. The German developer of RNA vaccines and immunotherapies said ...

U.S. FDA removes clinical hold on Investigational New Drug application for COVID-19-Influenza Combination and stand-alone influenza vaccine candidates Achieved total ...

German drugmaker BioNTech on Monday lowered its guidance for full-year revenue, citing COVID-19 uptake and price levels, inventory write-downs and Pfizer charges.

Dr. Anthony Fauci spoke at a rare briefing from the White House virus task force to reassure some public concerns about the two vaccines - one from Pfizer/BioNTech and the other by Moderna - after ...

Singapore is the first South-east Asian country to fully approve the use of the updated Pfizer-BioNTech vaccine – one of the two to be rolled out – for those who are at least six months old ...

On Aug. 22, the Food and Drug Administration approved and authorized newer formulations of the two mRNA vaccines, from Pfizer/BioNTech and Moderna, for ages 6 months and up. About a week later ...

Advancements in vaccine development for parasitic infections, particularly malaria, are crucial for reducing global health burdens in vulnerable populations.

EMVI = European malaria vaccine initiative; GLURP = Glutamate-rich protein; GSK = GlaxoSmithKline; LSA = Liver-stage antigen; LSP = Long-synthetic peptide; ME-TRAP = Multiepitope-thrombospondin ...